Conjugated Diene Rubber Modified With Polar Alkoxysilane, Method and Composition Thereof
申请人:TSRC Corporation
公开号:EP2604630B1
公开(公告)日:2015-03-18
Histamine H3 Agonist for use as Therapeutic Agent for a Lipid/Glucose Metabolic Disorder
申请人:Yoshimoto Ryo
公开号:US20100137391A1
公开(公告)日:2010-06-03
Disclosed are: novel use of an agonist histamine receptor H3 (e.g., Imetit) for prevention of obesity or the reduction of food intake; a method for evaluation of a compound for use as a therapeutic agent targeted to histamine receptor HR protein; and a compound provided by the method.
CONJUGATED DIENE RUBBER MODIFIED WITH POLAR ALKOXYSILANE, METHOD AND COMPOSITION THEREOF
申请人:Hsieh Chi-Chen
公开号:US20130150522A1
公开(公告)日:2013-06-13
A modified conjugated diene rubber is disclosed. A method for producing the modified conjugated diene rubber includes providing an alkali metal ion-containing conjugated diene rubber; and reacting the alkali metal ion-containing conjugated diene rubber with an alkoxysilane to generate the modified conjugated diene rubber, the alkoxysilane being of the structural formula:
wherein R
1
, R
2
, R
3
are each independently selected from a group consisting of oxygen-containing C
2
-C
12
group and nitrogen-containing C
3
-C
12
group, the oxygen-containing C
2
-C
12
group has a carbon atom directly connected to oxygen atom of the alkoxysilane, the nitrogen-containing C
1
-C
12
group has a nitrogen atom directly connected to oxygen atom of the alkoxysilane, and R
4
is selected from a group consisting of C
3
-C
12
of alkyl, alkenyl, aryl, and alkoxy.